Acumen Pharmaceuticals ABOS Stock
0.98 USD
{{ price }}
-1.022262%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
59.23M USD
LOW - HIGH [24H]
0.9
-
0.99 USD
VOLUME [24H]
437.96K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.71 USD
Acumen Pharmaceuticals Price Chart
Acumen Pharmaceuticals ABOS Financial and Trading Overview
| Acumen Pharmaceuticals stock price | 0.98 USD |
| Previous Close | 5.91 USD |
| Open | 5.9 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 5.59 - 6.14 USD |
| 52 Week Range | 3.19 - 10.97 USD |
| Volume | 198.34K USD |
| Avg. Volume | 190.03K USD |
| Market Cap | 230.15M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.71 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.57 USD |
ABOS Valuation Measures
| Enterprise Value | 101.3M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.5062501 |
| PEG Ratio (5 yr expected) | -0.48 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.2852235 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.062 |
Trading Information
Acumen Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 70.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.97 USD |
| 52 Week Low | 3.19 USD |
| 50-Day Moving Average | 4.72 USD |
| 200-Day Moving Average | 5.67 USD |
ABOS Share Statistics
| Avg. Volume (3 month) | 190.03K USD |
| Avg. Daily Volume (10-Days) | 185.19K USD |
| Shares Outstanding | 41.03M |
| Float | 14.92M |
| Short Ratio | 0.78 |
| % Held by Insiders | 15.52% |
| % Held by Institutions | 74.18% |
| Shares Short | 240.2K |
| Short % of Float | 0.77% |
| Short % of Shares Outstanding | 0.58% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.065% |
| Return on Equity (ttm) | -22.79% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -32361000 USD |
| EBITDA | -49124000 USD |
| Net Income Avi to Common (ttm) | -45034000 USD |
| Diluted EPS (ttm) | -1.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 140.41M USD |
| Total Cash Per Share (mrq) | 3.42 USD |
| Total Debt (mrq) | 67K USD |
| Total Debt/Equity (mrq) | 0.04 USD |
| Current Ratio (mrq) | 16.406 |
| Book Value Per Share (mrq) | 4.365 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -37029000 USD |
| Levered Free Cash Flow (ttm) | -22563750 USD |
Profile of Acumen Pharmaceuticals
| Country | United States |
| State | VA |
| City | Charlottesville |
| Address | 427 Park Street |
| ZIP | 22902 |
| Phone | 434 297 1000 |
| Website | https://acumenpharm.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 39 |
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Q&A For Acumen Pharmaceuticals Stock
What is a current ABOS stock price?
Acumen Pharmaceuticals ABOS stock price today per share is 0.98 USD.
How to purchase Acumen Pharmaceuticals stock?
You can buy ABOS shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Acumen Pharmaceuticals?
The stock symbol or ticker of Acumen Pharmaceuticals is ABOS.
Which industry does the Acumen Pharmaceuticals company belong to?
The Acumen Pharmaceuticals industry is Biotechnology.
How many shares does Acumen Pharmaceuticals have in circulation?
The max supply of Acumen Pharmaceuticals shares is 60.57M.
What is Acumen Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Acumen Pharmaceuticals PE Ratio is now.
What was Acumen Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Acumen Pharmaceuticals EPS is -1.71 USD over the trailing 12 months.
Which sector does the Acumen Pharmaceuticals company belong to?
The Acumen Pharmaceuticals sector is Healthcare.
Acumen Pharmaceuticals ABOS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ Global Select Market Com NQGS | 7625.89 USD — |
-5.84
|
— — | 7621.56 USD — | 7894.21 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 3904.12 USD — |
-5.49
|
— — | 3901.51 USD — | 4064.61 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
- {{ link.label }} {{link}}